Literature DB >> 25320291

Nonstructural protein 5A (NS5A) and human replication protein A increase the processivity of hepatitis C virus NS5B polymerase activity in vitro.

Nagraj Mani1, Alexander Yuzhakov2, Olga Yuzhakov2, Joyce T Coll3, Jim Black3, Kumkum Saxena3, John R Fulghum3, Judith A Lippke3, B Govinda Rao4, Rene Rijnbrand2, Ann D Kwong2.   

Abstract

UNLABELLED: The precise role(s) and topological organization of different factors in the hepatitis C virus (HCV) RNA replication complex are not well understood. In order to elucidate the role of viral and host proteins in HCV replication, we have developed a novel in vitro replication system that utilizes a rolling-circle RNA template. Under close-to-physiological salt conditions, HCV NS5BΔ21, an RNA-dependent RNA polymerase, has poor affinity for the RNA template. Human replication protein A (RPA) and HCV NS5A recruit NS5BΔ21 to the template. Subsequently, NS3 is recruited to the replication complex by NS5BΔ21, resulting in RNA synthesis stimulation by helicase. Both RPA and NS5A(S25-C447), but not NS5A(S25-K215), enabled the NS5BΔ21-NS3 helicase complex to be stably associated with the template and synthesize RNA product in a highly processive manner in vitro. This new in vitro HCV replication system is a useful tool that may facilitate the study of other replication factors and aid in the discovery of novel inhibitors of HCV replication. IMPORTANCE: The molecular mechanism of hepatitis C virus (HCV) replication is not fully understood, but viral and host proteins collaborate in this process. Using a rolling-circle RNA template, we have reconstituted an in vitro HCV replication system that allows us to interrogate the role of viral and host proteins in HCV replication and delineate the molecular interactions. We showed that HCV NS5A(S25-C447) and cellular replication protein A (RPA) functionally cooperate as a processivity factor to stimulate HCV replication by HCV NS5BΔ21 polymerase and NS3 helicase. This system paves the way to test other proteins and may be used as an assay for discovery of HCV inhibitors.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25320291      PMCID: PMC4301100          DOI: 10.1128/JVI.01677-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  98 in total

1.  Interaction between the T4 helicase loading protein (gp59) and the DNA polymerase (gp43): unlocking of the gp59-gp43-DNA complex to initiate assembly of a fully functional replisome.

Authors:  Jun Xi; Zhiquan Zhang; Zhihao Zhuang; Jingsong Yang; Michelle M Spiering; Gordon G Hammes; Stephen J Benkovic
Journal:  Biochemistry       Date:  2005-05-31       Impact factor: 3.162

2.  Structure of the hepatitis C virus RNA helicase domain.

Authors:  N Yao; T Hesson; M Cable; Z Hong; A D Kwong; H V Le; P C Weber
Journal:  Nat Struct Biol       Date:  1997-06

3.  RNA-dependent RNA polymerase of hepatitis C virus.

Authors:  R De Francesco; S E Behrens; L Tomei; S Altamura; J Jiricny
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

4.  A novel recombinant single-chain hepatitis C virus NS3-NS4A protein with improved helicase activity.

Authors:  A Y Howe; R Chase; S S Taremi; C Risano; B Beyer; B Malcolm; J Y Lau
Journal:  Protein Sci       Date:  1999-06       Impact factor: 6.725

5.  Yeast replication factor-A functions in the unwinding of the SV40 origin of DNA replication.

Authors:  S J Brill; B Stillman
Journal:  Nature       Date:  1989-11-02       Impact factor: 49.962

6.  The NS4A protein of hepatitis C virus promotes RNA-coupled ATP hydrolysis by the NS3 helicase.

Authors:  Rudolf K F Beran; Brett D Lindenbach; Anna Marie Pyle
Journal:  J Virol       Date:  2009-01-19       Impact factor: 5.103

7.  Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase.

Authors:  Timothy L Tellinghuisen; Joseph Marcotrigiano; Charles M Rice
Journal:  Nature       Date:  2005-05-19       Impact factor: 49.962

8.  Mutations in hepatitis C virus RNAs conferring cell culture adaptation.

Authors:  V Lohmann; F Körner; A Dobierzewska; R Bartenschlager
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

9.  Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity.

Authors:  Yukihiro Shirota; Hong Luo; Weiping Qin; Shuichi Kaneko; Tatsuya Yamashita; Kenichi Kobayashi; Seishi Murakami
Journal:  J Biol Chem       Date:  2002-01-18       Impact factor: 5.157

10.  Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli.

Authors:  E Ferrari; J Wright-Minogue; J W Fang; B M Baroudy; J Y Lau; Z Hong
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more
  3 in total

1.  Full-dose sofosbuvir plus low-dose ribavirin for hepatitis C virus genotype 2-infected patients on hemodialysis.

Authors:  Hee Yeon Seo; Myeong-Sook Seo; Sun-Young Yoon; Jong Wook Choi; Soon Young Ko
Journal:  Korean J Intern Med       Date:  2019-05-10       Impact factor: 2.884

Review 2.  Viral Hepatitis - The Road Traveled and the Journey Remaining.

Authors:  Ghulam Fareed Malik; Noval Zakaria; Muhammad Ibrahim Majeed; Faisal Wasim Ismail
Journal:  Hepat Med       Date:  2022-03-09

Review 3.  Hepatitis C Viral Replication Complex.

Authors:  Hui-Chun Li; Chee-Hing Yang; Shih-Yen Lo
Journal:  Viruses       Date:  2021-03-22       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.